Work

Preliminary results of a randomized phase II study comparing two schedules of temozolomide in combination with sorafenib in patients with advanced melanoma

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.8009

Authors: R. K. Amaravadi, L. M. Schuchter, A. Kramer, S. F. Barth, J. Villanueva, A. B. Troxel, D. A. Tuveson, K. L. Nathanson, P. J. O’Dwyer, K. T. Flaherty

Institution: University of Pennsylvania

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2595040182

Cites:

Cited by: 59

Related to: 10